CSF1R and cancer: Mechanistic studies revealed that DNA damage-induced kinase ABL1 enhanced CSF-1 expression, while selective inhibition of its receptor kinase CSF1R (CD115) by GW2850 or PLX3397 inhibitors hampered TAM recruitment and suppressed tumor growth in murine prostate [124] and thyroid [125] cancer models.